Desmoid tumors - A characterization of patients seen at Mayo Clinic 1976-1999

Taya Fallen, Marcia Wilson, Bruce Morlan, Noralane Morey Lindor

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Desmoid tumors occur with high frequency in individuals with Familial Adenomatous Polyposis (FAP). Because of this, individuals developing desmoid tumors may be referred for genetic risk assessment. Determining whether a person has a FAP-related desmoid tumor or a sporadic desmoid can be challenging. We sought to characterize the patients who were seen at our institution to determine if there were clinical differences in presentation between FAP-associated and sporadic desmoid tumors. We searched the Mayo Clinic-modified H-ICDA (Hospital adaptation of the International Classification of Diseases) diagnostic codes for all diagnoses of desmoid tumors in patients seen between 1976 and 1999. Charts were reviewed to determine accuracy of diagnosis, age when seen, gender, site of tumor, and presence of polyposis. A total of 454 patients (174 males and 280 females) met the search criterion. Of the 447 patients on whom all data was obtained, 70 had FAP and 377 had no evidence of FAP. The female/male ratio for FAP cases was 1.12 compared to female/male ratio of 1.71 for non-FAP cases. (P=0.17). Location of development of desmoid tumors was correlated with but not specific for distinguishing FAP from non-FAP desmoids. Abdominal desmoids comprised the majority of FAP desmoids and extra-abdominal desmoids comprised the majority of non-FAP desmoids (P<0.001) but age was not a discriminating factor. Using Bayesian analysis, we demonstrate how these findings can assist genetic professionals in their evaluation of patients with desmoid tumors by providing prior probabilities of FAP based upon clinical presentation.

Original languageEnglish (US)
Pages (from-to)191-194
Number of pages4
JournalFamilial Cancer
Volume5
Issue number2
DOIs
StatePublished - Jun 2006

Fingerprint

Aggressive Fibromatosis
Adenomatous Polyposis Coli
Neoplasms
Bayes Theorem
International Classification of Diseases

Keywords

  • Desmoid
  • Desmoid tumors
  • Familial adenomatous polyposis (FAP)
  • FAP risk assessment
  • Hereditary colorectal cancer

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Desmoid tumors - A characterization of patients seen at Mayo Clinic 1976-1999. / Fallen, Taya; Wilson, Marcia; Morlan, Bruce; Lindor, Noralane Morey.

In: Familial Cancer, Vol. 5, No. 2, 06.2006, p. 191-194.

Research output: Contribution to journalArticle

Fallen, Taya ; Wilson, Marcia ; Morlan, Bruce ; Lindor, Noralane Morey. / Desmoid tumors - A characterization of patients seen at Mayo Clinic 1976-1999. In: Familial Cancer. 2006 ; Vol. 5, No. 2. pp. 191-194.
@article{e23ee704dab34ec8bb7bf822ddb55387,
title = "Desmoid tumors - A characterization of patients seen at Mayo Clinic 1976-1999",
abstract = "Desmoid tumors occur with high frequency in individuals with Familial Adenomatous Polyposis (FAP). Because of this, individuals developing desmoid tumors may be referred for genetic risk assessment. Determining whether a person has a FAP-related desmoid tumor or a sporadic desmoid can be challenging. We sought to characterize the patients who were seen at our institution to determine if there were clinical differences in presentation between FAP-associated and sporadic desmoid tumors. We searched the Mayo Clinic-modified H-ICDA (Hospital adaptation of the International Classification of Diseases) diagnostic codes for all diagnoses of desmoid tumors in patients seen between 1976 and 1999. Charts were reviewed to determine accuracy of diagnosis, age when seen, gender, site of tumor, and presence of polyposis. A total of 454 patients (174 males and 280 females) met the search criterion. Of the 447 patients on whom all data was obtained, 70 had FAP and 377 had no evidence of FAP. The female/male ratio for FAP cases was 1.12 compared to female/male ratio of 1.71 for non-FAP cases. (P=0.17). Location of development of desmoid tumors was correlated with but not specific for distinguishing FAP from non-FAP desmoids. Abdominal desmoids comprised the majority of FAP desmoids and extra-abdominal desmoids comprised the majority of non-FAP desmoids (P<0.001) but age was not a discriminating factor. Using Bayesian analysis, we demonstrate how these findings can assist genetic professionals in their evaluation of patients with desmoid tumors by providing prior probabilities of FAP based upon clinical presentation.",
keywords = "Desmoid, Desmoid tumors, Familial adenomatous polyposis (FAP), FAP risk assessment, Hereditary colorectal cancer",
author = "Taya Fallen and Marcia Wilson and Bruce Morlan and Lindor, {Noralane Morey}",
year = "2006",
month = "6",
doi = "10.1007/s10689-005-5959-5",
language = "English (US)",
volume = "5",
pages = "191--194",
journal = "Familial Cancer",
issn = "1389-9600",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Desmoid tumors - A characterization of patients seen at Mayo Clinic 1976-1999

AU - Fallen, Taya

AU - Wilson, Marcia

AU - Morlan, Bruce

AU - Lindor, Noralane Morey

PY - 2006/6

Y1 - 2006/6

N2 - Desmoid tumors occur with high frequency in individuals with Familial Adenomatous Polyposis (FAP). Because of this, individuals developing desmoid tumors may be referred for genetic risk assessment. Determining whether a person has a FAP-related desmoid tumor or a sporadic desmoid can be challenging. We sought to characterize the patients who were seen at our institution to determine if there were clinical differences in presentation between FAP-associated and sporadic desmoid tumors. We searched the Mayo Clinic-modified H-ICDA (Hospital adaptation of the International Classification of Diseases) diagnostic codes for all diagnoses of desmoid tumors in patients seen between 1976 and 1999. Charts were reviewed to determine accuracy of diagnosis, age when seen, gender, site of tumor, and presence of polyposis. A total of 454 patients (174 males and 280 females) met the search criterion. Of the 447 patients on whom all data was obtained, 70 had FAP and 377 had no evidence of FAP. The female/male ratio for FAP cases was 1.12 compared to female/male ratio of 1.71 for non-FAP cases. (P=0.17). Location of development of desmoid tumors was correlated with but not specific for distinguishing FAP from non-FAP desmoids. Abdominal desmoids comprised the majority of FAP desmoids and extra-abdominal desmoids comprised the majority of non-FAP desmoids (P<0.001) but age was not a discriminating factor. Using Bayesian analysis, we demonstrate how these findings can assist genetic professionals in their evaluation of patients with desmoid tumors by providing prior probabilities of FAP based upon clinical presentation.

AB - Desmoid tumors occur with high frequency in individuals with Familial Adenomatous Polyposis (FAP). Because of this, individuals developing desmoid tumors may be referred for genetic risk assessment. Determining whether a person has a FAP-related desmoid tumor or a sporadic desmoid can be challenging. We sought to characterize the patients who were seen at our institution to determine if there were clinical differences in presentation between FAP-associated and sporadic desmoid tumors. We searched the Mayo Clinic-modified H-ICDA (Hospital adaptation of the International Classification of Diseases) diagnostic codes for all diagnoses of desmoid tumors in patients seen between 1976 and 1999. Charts were reviewed to determine accuracy of diagnosis, age when seen, gender, site of tumor, and presence of polyposis. A total of 454 patients (174 males and 280 females) met the search criterion. Of the 447 patients on whom all data was obtained, 70 had FAP and 377 had no evidence of FAP. The female/male ratio for FAP cases was 1.12 compared to female/male ratio of 1.71 for non-FAP cases. (P=0.17). Location of development of desmoid tumors was correlated with but not specific for distinguishing FAP from non-FAP desmoids. Abdominal desmoids comprised the majority of FAP desmoids and extra-abdominal desmoids comprised the majority of non-FAP desmoids (P<0.001) but age was not a discriminating factor. Using Bayesian analysis, we demonstrate how these findings can assist genetic professionals in their evaluation of patients with desmoid tumors by providing prior probabilities of FAP based upon clinical presentation.

KW - Desmoid

KW - Desmoid tumors

KW - Familial adenomatous polyposis (FAP)

KW - FAP risk assessment

KW - Hereditary colorectal cancer

UR - http://www.scopus.com/inward/record.url?scp=33744741054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744741054&partnerID=8YFLogxK

U2 - 10.1007/s10689-005-5959-5

DO - 10.1007/s10689-005-5959-5

M3 - Article

C2 - 16736290

AN - SCOPUS:33744741054

VL - 5

SP - 191

EP - 194

JO - Familial Cancer

JF - Familial Cancer

SN - 1389-9600

IS - 2

ER -